Skip to content

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown

Sichenzia Ross Friedman Ference LLP Advises Xenetic Biosciences in Reverse Merger and Direct PIPE Investment.

MusclePharm Corporation

Intellicheck Mobilisa

Paulson Capital Corp

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

PARTNER ROSS DAVID CARMEL AGAIN NAMED “SUPER LAWYER RISING STAR” BY THOMSON REUTERS

Carmel, Milazzo & Feil Obtain Successful Appeal and Vacatur of FINRA Disciplinary Finding

SEC Extends Filing Deadlines for Public Companies and Registered Investment Advisers Affected by COVID-19

Business Interruption Insurance

Coronavirus (Covid 19) Update

Founding Partner Gregory Sichenzia Featured in Law360 Article on Coronavirus-fueled Market Volatility

Sichenzia Ross Ference LLP Congratulates Beyond Air Inc. on NASDAQ Closing Bell Ringing Ceremony

Carmel, Milazzo & Feil LLP Represents Co-Diagnostics In $4.2 Million Registered Direct Offering

Carmel, Milazzo & Feil LLP Represents Co-Diagnostics In $10.2 Million Registered Direct Offering

Carmel, Milazzo & Feil LLP Represents Co-Diagnostics In $5 Million Registered Direct Offering

Sichenzia Ross Ference LLP Successfully Defends Client in Hostile Proxy Contest

Sichenzia Ross Ference LLP Sponsors the 32nd Annual ROTH Conference

SRF CLIENT ALERT: Major Changes for Your IRA Account

Sichenzia Ross Ference LLP Achieves Voluntary Dismissals in Federal Securities Class Action Lawsuit and Shareholder Derivative Action

Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article